Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 256, pseudogene (RNU6-256P)
- Target
- RNU6-256P
- Molecular classification
- Pseudogene, Non-coding RNA (derived from small nuclear RNA)
01
Overview
RNU6-256P is a member of the U6 small nuclear RNA pseudogene family. U6 snRNA is a highly conserved, non-coding RNA critical for pre-mRNA splicing as part of the spliceosome complex, where it participates in post-transcriptional modification. Pseudogenes like RNU6-256P are non-functional sequences originating from retrotranspositional events or gene duplication, and do not encode active RNA or protein. Multiple U6 snRNA pseudogenes exist in vertebrate genomes, serving as evolutionary markers and evidence of retrotranspositional dynamics. Unlike functional U6 snRNA, pseudogenes have no known biological, disease, or pharmacological roles. Their presence reflects genome evolution, not active cellular function.
- Other names
- RNU6-256PRNA, U6 small nuclear 256 pseudogeneU6 snRNA pseudogene
02
Mechanism of action
None. No mechanism of action exists, as the pseudogene is not targeted by drugs or therapies
03
Biological functions
None. As a pseudogene, RNU6-256P does not have a biological function; it is a retrotransposed or duplicated copy of functional U6 snRNA
04
Disease associations
None established. Pseudogenes like RNU6-256P are not known to have disease associations or causative roles
05
Safety considerations
None relevant, since this is not a therapeutic target or gene with a known functional product
06
Interacting drugs
None. No drugs interact with this molecule, as it is not a functional gene product or protein
07
Biomarkers
None. Pseudogenes, including RNU6-256P, are generally not used as biomarkers for patient selection or efficacy monitoring
Beyond the preview
Go deeper on RNA, U6 small nuclear 256, pseudogene (RNU6-256P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 256, pseudogene (RNU6-256P).